for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Healthcare

BRIEF-Synthetic Biologics Enters Option To License Intellectual Property For Use Of SYN-020 For Age-Related Metabolic, Inflammatory Diseases

May 27 (Reuters) - Synthetic Biologics Inc:

* SYNTHETIC BIOLOGICS ENTERS OPTION TO LICENSE INTELLECTUAL PROPERTY FOR USE OF SYN-020 TO TREAT, PREVENT AGE-RELATED METABOLIC AND INFLAMMATORY DISEASES Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up